Board Chair Joseph Bower , D.B.A. announces intention not to stand for re-election at 2021 Annual Meeting Jeffery Thompson succeeds Dr. Bower as Chair of the Board BEDFORD, Mass. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation,
BEDFORD, Mass. , Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R.
Seasoned financial executive brings broad medical device industry experience and track record of value creation BEDFORD, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with
Increased Total Revenue 1% Year-over-Year to $30.7 Million Accelerated the Commercial Integration of Parcus Medical and Arthrosurface Organizations Launching Seven FDA-Cleared Orthopedic and Sports Medicine Products Through Q3 2020 BEDFORD, Mass. , July 30, 2020 (GLOBE NEWSWIRE) -- Anika
Innovative Products Designed to Meet Needs of Surgeons and their Patients in Joint Preservation and Restoration Procedures BEDFORD, Mass. , July 20, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions
BEDFORD, Mass. , July 16, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that the Company plans to
Sylvia Cheung to Step Down in August 2020 Company Initiates Search for Successor BEDFORD, Mass. , June 02, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products across the orthopedic early
BEDFORD, Mass. --(BUSINESS WIRE)--May 12, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Blanchard , Ph.D., President and Chief Executive Officer, and Sylvia Cheung , Chief Financial Officer,
Total Revenue Increases 43% Year-over-Year Continued Progress on Integration of Parcus Medical and Arthrosurface Acquisitions Withdrawing Full Year 2020 Financial Guidance Well Positioned to Manage through COVID-19 Pandemic BEDFORD, Mass. , May 07, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc.
Seasoned industry executive with experience leading global joint preservation and restoration businesses BEDFORD, Mass. --(BUSINESS WIRE)--Apr. 27, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its
